Artificial intelligence in diabetes mellitus: a tertiary review of the current landscape and future research directions

Artificial intelligence (AI) is transforming diabetes mellitus (DM) care by enabling earlier detection, precision management, and data-driven decision support across clinical settings. However, the growing number of systematic reviews has produced a fragmented evidence base, making it difficult to assess the field’s maturity, methodological quality, and clinical readiness, and leaving future research directions largely undefined. To clarify this landscape, we conducted a tertiary review that synthesizes 70 systematic reviews on AI applications across type 1, type 2, and gestational diabetes and their major complications. Our analysis reveals an accelerating research trajectory since 2020, yet activity remains concentrated in type 1 and type 2 diabetes and in image-based applications such as diabetic retinopathy and foot-ulcer screening, with gestational and kidney disease still underexplored. Methodological rigor is inconsistent, with wide variation in search coverage, quality appraisal, and reporting standards. Across the literature, recurrent challenges include data bias, limited external validation, and barriers to clinical implementation. By integrating evidence across disease types, data modalities, and levels of care, this review shows that AI in diabetes is at a transitional stage. The field is technically advanced yet remains clinically fragmented and lacks a coherent roadmap for translation into practice. Expanding research into underrepresented areas such as multimodal data integration, natural-language processing of clinical text, and reinforcement learning for adaptive decision support will be essential to bridge this gap. This synthesis consolidates over a decade of secondary evidence and clarifies the structural and methodological requirements for achieving trustworthy, equitable, and scalable AI-driven diabetes care.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-17
DOI
https://doi.org/10.3389/fendo.2026.1933129
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial intelligence in diabetes mellitus: a tertiary review of the current landscape and future research directions

Sander M. W. Janssen
1 links
Frontiers in Endocrinology
Artificial Intelligence in Healthcare and Education
article

Artificial intelligence in diabetes mellitus: a tertiary review of the current landscape and future research directions

Sander M. W. Janssen
article en

Abstract

Artificial intelligence (AI) is transforming diabetes mellitus (DM) care by enabling earlier detection, precision management, and data-driven decision support across clinical settings. However, the growing number of systematic reviews has produced a fragmented evidence base, making it difficult to assess the field’s maturity, methodological quality, and clinical readiness, and leaving future research directions largely undefined. To clarify this landscape, we conducted a tertiary review that synthesizes 70 systematic reviews on AI applications across type 1, type 2, and gestational diabetes and their major complications. Our analysis reveals an accelerating research trajectory since 2020, yet activity remains concentrated in type 1 and type 2 diabetes and in image-based applications such as diabetic retinopathy and foot-ulcer screening, with gestational and kidney disease still underexplored. Methodological rigor is inconsistent, with wide variation in search coverage, quality appraisal, and reporting standards. Across the literature, recurrent challenges include data bias, limited external validation, and barriers to clinical implementation. By integrating evidence across disease types, data modalities, and levels of care, this review shows that AI in diabetes is at a transitional stage. The field is technically advanced yet remains clinically fragmented and lacks a coherent roadmap for translation into practice. Expanding research into underrepresented areas such as multimodal data integration, natural-language processing of clinical text, and reinforcement learning for adaptive decision support will be essential to bridge this gap. This synthesis consolidates over a decade of secondary evidence and clarifies the structural and methodological requirements for achieving trustworthy, equitable, and scalable AI-driven diabetes care.

Frontiers in EndocrinologyVol. 17
Wageningen University & Research (NL)
Ministerie van Volksgezondheid, Welzijn en Sport
Good health and well-being
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon